Luteolin inhibits breast cancer stem cells both in vitro and in preclinical studies due to the inhibition of VEGF and the suppression of angiogenesis, the inhibition of medroxyprogesterone acetate stem-cell like properties of breast cancer cells, and the down-regulation of mammosphere formation [123]. This evidence concerns the gene VEGFA and breast carcinoma.